Liberty Oilfield Services (NYSE:LBRT) Now Covered by The Goldman Sachs Group

Equities research analysts at The Goldman Sachs Group began coverage on shares of Liberty Oilfield Services (NYSE:LBRT) in a report released on Wednesday, Benzinga reports. The brokerage set a “buy” rating and a $17.00 price target on the stock. The Goldman Sachs Group’s target price would suggest a potential upside of 20.82% from the stock’s current price.

A number of other research analysts also recently weighed in on LBRT. Citigroup upped their target price on Liberty Oilfield Services from $12.00 to $14.00 in a report on Monday, February 8th. Bank of America downgraded Liberty Oilfield Services from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $13.50 to $11.00 in a report on Monday, February 8th. TheStreet raised Liberty Oilfield Services from a “d” rating to a “c-” rating in a research report on Thursday, February 4th. Morgan Stanley boosted their price target on Liberty Oilfield Services from $13.00 to $15.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 31st. Finally, Evercore ISI raised Liberty Oilfield Services from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $12.00 to $15.00 in a research report on Wednesday, January 27th. Two analysts have rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company’s stock. Liberty Oilfield Services currently has a consensus rating of “Hold” and an average price target of $12.25.

Shares of NYSE:LBRT opened at $14.07 on Wednesday. Liberty Oilfield Services has a 1 year low of $4.72 and a 1 year high of $14.78. The company has a market cap of $2.54 billion, a PE ratio of -12.91 and a beta of 3.31. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.03 and a quick ratio of 1.57. The stock’s 50-day moving average is $11.85 and its 200 day moving average is $11.23.

(Ad)

Psychedelic Therapy Clinics are popping up all over LA and Arizona. Some of them charge up to $2,000 for a full treatment… this is an emerging trend every investor should consider.

Liberty Oilfield Services (NYSE:LBRT) last posted its earnings results on Tuesday, April 27th. The company reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Liberty Oilfield Services had a negative return on equity of 11.01% and a negative net margin of 8.20%. The firm had revenue of $552.03 million for the quarter, compared to the consensus estimate of $490.64 million. Analysts expect that Liberty Oilfield Services will post -1.34 EPS for the current fiscal year.

In related news, President Ron Gusek sold 25,000 shares of the company’s stock in a transaction that occurred on Monday, February 22nd. The stock was sold at an average price of $11.38, for a total value of $284,500.00. Following the transaction, the president now directly owns 1,457,101 shares of the company’s stock, valued at approximately $16,581,809.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP R Sean Elliott sold 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 5th. The shares were sold at an average price of $13.00, for a total value of $78,000.00. Insiders sold a total of 7,583,553 shares of company stock worth $98,629,867 over the last ninety days. 8.50% of the stock is currently owned by insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its stake in Liberty Oilfield Services by 12.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,320,684 shares of the company’s stock valued at $13,616,000 after buying an additional 144,011 shares during the last quarter. SG Americas Securities LLC purchased a new stake in Liberty Oilfield Services during the 4th quarter valued at $285,000. Panagora Asset Management Inc. purchased a new stake in Liberty Oilfield Services during the 4th quarter valued at $213,000. Nuveen Asset Management LLC raised its stake in Liberty Oilfield Services by 40.7% during the 4th quarter. Nuveen Asset Management LLC now owns 392,128 shares of the company’s stock valued at $4,043,000 after buying an additional 113,413 shares during the last quarter. Finally, Guggenheim Capital LLC raised its stake in Liberty Oilfield Services by 15.4% during the 4th quarter. Guggenheim Capital LLC now owns 27,552 shares of the company’s stock valued at $284,000 after buying an additional 3,670 shares during the last quarter.

About Liberty Oilfield Services

Liberty Oilfield Services Inc provides hydraulic fracturing and wireline services, and related goods to onshore oil and natural gas exploration and production companies in North America. The company also offers hydraulic fracturing pressure pumping services, including pressure pumping and pumpdown perforating services; and operates two sand mines in the Permian Basin.

Recommended Story: What is a Futures Contract?

Analyst Recommendations for Liberty Oilfield Services (NYSE:LBRT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: How to Use the New Google Finance Tool

7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the “7 Healthcare Stocks Delivering Innovation in 2021”.